Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-09

FDA Approved: CEFDINIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cefdinir from Teva Pharmaceuticals USA, Inc., resulting in labeling updates for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefdinir (cefdinir)

Snippet

SUPPL AP for CEFDINIR (CEFDINIR)